Tag: ChatBots

Browse our exclusive articles!

Massive Bio Launches Game-Changing Chatbot Powered by ChatGPT for Easy Access to Oncology Trials at ASCO 2023

Massive Bio's AI chatbots, DrArturo and AskFiona, are set to revolutionize cancer care. These tools provide personalized information and assessments to patients, physicians, and site investigators, promoting patient empowerment and reducing reliance on hospital-specific healthcare. Powered by ChatGPT, they are expected to set new industry standards.

Alibaba’s DingTalk tests new AI features

Alibaba's DingTalk now offers AI functions like generating text, images, meeting notes, and chatbots. Access by typing /—Feishu is yet to test AI.

Benefits of Google Cloud for Your Business

Discover how Google Cloud Platform can simplify your business projects and websites. Benefit from unlimited data, BigQuery for analytics, app creation, and AI/ML features. Find advanced services for healthcare, live streaming, retail, and more. Plus, experience Google's unique approach to project management that sets it apart from competitors Amazon and Microsoft.

Beginner’s Guide to ChatGPT: Exploring the Upcoming Era of Artificial Intelligence.

Discover the power of Generative AI with ChatGPT: a chatbot that uses natural language processing to bring human-like conversation to technology.

Errors in ChatGPT: Hallucinated Whoppers Instead of Being Pedantic

ChatGPT, an AI-powered chatbot once known for helping users find information on various topics, has been found to provide false or misleading information to its users, who should remain sceptical of the factual accuracy of its responses. Cyber-security specialist Herbert Lin demonstrated that the tool can generate false information, highlighting that users should be especially cautious when seeking academic knowledge.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img